New insights in sarcoma oncogenesis: a comprehensive analysis of a large series of 160 soft tissue sarcomas with complex genomics

Archive ouverte

Gibault, Laure | Pérot, Gaëlle | Chibon, Frédéric | Bonnin, Sarah | Lagarde, Pauline | Terrier, Philippe | Coindre, Jean‐michel | Aurias, Alain

Edité par CCSD ; Wiley -

International audience. Abstract Adult soft tissue sarcomas (STS) are rare tumours of mesenchymal lineage. Based on cytogenetic and comparative genomic hybridization (CGH) data, they can be divided into ‘STS with simple genomics’, displaying a characteristic genetic alteration, and ‘STS with complex genomics’ (SCG), where multiple genomic alterations occur. This latter group is mostly composed of leiomyosarcomas (LMS) and pleiomorphic undifferentiated tumours previously labelled as ‘malignant fibrous histiocytomas’ (MFH), corresponding in fact to myxofibrosarcomas (MFS), pleiomorphic liposarcomas/rhabdomyosarcomas (P‐LPS, P‐RMS), and undifferentiated pleiomorphic sarcomas (UPS). Their pathobiology is still not well understood, leading to challenges in diagnosis and therapeutic management. We report here a comprehensive study encompassing array‐CGH and transcriptome analysis data of a large series of 160 SCG. Non‐supervised clustering of transcriptome data led to the identification of five groups of tumours, one of them (group A) corresponding to well‐differentiated LMS and the other four (B–E) to ‘MFH’ and poorly differentiated LMS. Welch analysis of transcriptome data in these groups allowed us to retrieve several genes of potential interest. Among them, RB1 alteration is a constant thread in SCG, often associated with RBL2 loss. PTEN tumour suppressor deletion would also stand out as a major recurrent event, especially in groups A, C, and D. The WNT canonical pathway could be potentially involved, as demonstrated by up‐regulation of one of its inhibitors, DKK1 , in groups D and E, whereas DKK1 is significantly down‐regulated in groups A, B, and C. These data suggest a very complex interplay between pathways downstream of PTEN and the WNT canonical pathway, providing new hints about SCG pathobiology and their potential therapeutic targets. Copyright © 2010 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Consulter en ligne

Suggestions

Du même auteur

From PTEN loss of expression to RICTOR role in smooth muscle differentiation: complex involvement of the mTOR pathway in leiomyosarcomas and pleomorphic sarcomas

Archive ouverte | Gibault, Laure | CCSD

International audience

YAP1 and VGLL3 , encoding two cofactors of TEAD transcription factors, are amplified and overexpressed in a subset of soft tissue sarcomas

Archive ouverte | Hélias-Rodzewicz, Zofia | CCSD

International audience. Abstract In a series of 404 adult soft tissue sarcomas, analyzed by array‐CGH, we have observed in approximately 10% of them a genomic amplification of either chromosome bands 11q22 or 3p12. ...

Constant p53 Pathway Inactivation in a Large Series of Soft Tissue Sarcomas with Complex Genetics

Archive ouverte | Pérot, Gaëlle | CCSD

International audience

Chargement des enrichissements...